Member Info for mulledwine

http://www.investegate.co.uk/uk-plc-(atuk)/rns/award-of-framework-for-social-care-emarketplaces/201212170700156291T/

Capital Drilling Limited (CAPD: LN), the emerging and developing markets drilling company, notes the announcement made today by Centamin PLC regarding the resumption of gold exports. The Company awaits further information from Centamin PLC regarding the reopening of operations at Sukari. We look forward to providing a further update to the market as soon as possible.

http://www.investegate.co.uk/capital-drilling-ltd-(capd)/rns/egypt-operations/201212170700406552T/

Canaccord Genuity maintained its "buy" recommendation on insolvency firm Begbies Traynor (BEG) but lowered the target price by 8% to 40p. This decision comes on the back of the firm's interim results, which showed revenues down by 12.6% to 26.1 million pounds and also illustrated a 0.9 million pounds fall in profits to 3.2 million pounds. The broker notes that past recessions have illustrated a lag between the bottom of the cycle and peak insolvency rates and to this end feels that it is unlikely that there will be any marked improvement in performance in the near-term future but believes things should pick up from 2014 onwards

Daniel Stewart reiterated its "buy" stance on 888 Holdings (888), increasing its target price from 120p to 130p. This comes on the back of the online gambling firm's agreement with Facebook to offer real money gaming connected to the social media site. The broker notes that many Facebook users currently play the (play-for-fun) version of 888's games via the Facebook website and believes that the conversion of some of these customers into real money gamers could prove to be lucrative for the firm

Further improvement in margin to drive share price up The shares are trading at a premium to our mean prospective PER for UK Tech hardware companies (11.4x excluding semiconductors) but in line for EV/EBITDA (7.3x vs 7.7x mean). We believe that the premium P/E is justified given Zytronic’s higher than average EBIT margin). While mindful of the potential for short-term weakness if H113 results are behind strong H112 comparatives, we believe that this stock could be an interesting margin expansion play

http://www.edisoninvestmentresearch.co.uk/researchreports/Zytronic141212qv.pdf

Valuation: Favourable balance of risk Our estimates are a touch below consensus for the closing year and in line for FY13, giving a prospective 13x P/E. This might seem full for a flat underlying performance, but, with a genuine recovery in earnings to come (the largest division especially is well positioned for a broadening of market demand) and the extended development scenario outlined above, we see the balance of risk tilted in favour of outperformance

http://www.edisoninvestmentresearch.co.uk/researchreports/LUPUpdate141212.pdf

Brooks Macdonald Group Buy 07-Dec-12 £14,903.10 Simon Jackson 1,142 @ 1,305.00p Brooks Macdonald Group Buy 07-Dec-12 £14,903.10 Nicholas Hugh Lawes 1,142 @ 1,305.00p

Brooks Macdonald Group Buy 07-Dec-12 £26,100.00 Richard Spencer 2,000 @ 1,305.00p Brooks Macdonald Group Buy 07-Dec-12 £24,847.20 Andrew William Shepherd 1,904 @ 1,305.00p

Brooks Macdonald Group Buy 07-Dec-12 £29,832.30 Jonathan Gumpel 2,286 @ 1,305.00p Brooks Macdonald Group Buy 07-Dec-12 £29,832.30 Chris A MacDonald 2,286 @ 1,305.00p

Bullabulling Gold Limited (DI) Buy 13-Dec-12 £26,737.83 Peter John Mansell 450,000 @ 5.94p

Sir Ron Brierley, a non-executive director of Guinness Peat Group (GPG) sold a massive chunk of shares in the investment holding company this week. The company announced on Friday morning that Brierley sold five million shares in the company at a price of A$0.475 (31.04p), earning himself around A$2.38m (around £1.55m). The sales took his stake down to just under 37m shares, representing 2.33% of the company's total voting rights.

N+1 Singer stuck with its "buy" recommendation on pig semen company Genus (GNS) with a target price of 1,678p. The broker believes that the company is in a good position to benefit from the long-term steady increase in demand for animal protein, which has already driven a "remarkably consistent" financial performance. The broker also notes the appointment of Stephen Wilson, currently CFO at Misys, as FD who will take up the post in March next year and believes he has the experience to drive growth in the long-term. The shares lost 11p to 1,399p.

Shore Capital maintained its "buy" recommendation on coach operator National Express (NEX) after the company released an encouraging pre-closing trading update. The broker was impressed with the 3% year-on-year increase in both Spanish and North American revenues, boosted by a recovery in the schoolbus business and other contract wins. Overall, the broker believes that the group's financial position is strong and that the company is in a good position in terms of cash generation. The shares grew by 7.7p to 187.9p.

Canaccord Genuity reiterated its "buy" recommendation on Advanced Medical Solutions (AMS) but lowered its target price by 3% to 90p. This comes on the back of a set of interim results which the broker believes were not quite as strong as they could have been, as pre-tax profits are expected to be slightly lower than the 12.5 million forecast for the full calendar year. However, the broker does acknowledge that sales of the company's Liquiband wound care product could be a source of long-term margin growth. The shares fell by 10.5p to 58.5p

GECR Hambledon Mining Offer declared unconditional and Drilling Update Hambledon Mining, the Kazakhstan-based gold miner, has announced an update on underground drilling operations taking place at its Sekisovskoye mine. 6,343m has been drilled since June 2012, with highlights including twelve intersections with a gold concentration of 3.55 – 10.57g/tonne with lengths of 4.7 - 24 metres (m), and one further significant intersection of 22.77g/tonne at 2.4m. This is the group’s first major update since the cash only partial offer was declared wholly unconditional on 7th December 2012. We recommend the shares as Speculative Buy with a 5.5p target price.

RWS is probably one of the few businesses that floated nine years ago and have grown sales, profits and dividends each year since. The company provides translation and other services to corporates issuing patents in a variety of jurisdictions to protect their intellectual property. This is a growth area, especially in Asia, where western companies want to ensure that their products are protected against unlicensed competition. Meanwhile, RWS is starting the process the other way, signing up a couple of Chinese producers that want to ensure they can launch in western markets. Inevitably, patent applications rise and fall with global economic trends, but the long-term trend is upwards — international patent applications were up 11% in 2011 on the previous year. The shares have been strong performers this year, up 22% despite an 8% fall yesterday on profit-taking. On 16 times’ earnings, that looks like a decent entry point for long-term growth, Tempus believes.

Analysts were being steered towards a more cautious outlook for 2013 from John Wood Group, the energy services company, on Thursday, even if the latest trading statement is upbeat enough. The company has performed extraordinarily well during the global downturn. The engineering side has seen earnings growth in the 30% area in 2011 and this year as well. A note from Credit Suisse yesterday estimated that another of Wood’s three divisions, production services, has grown earnings annually by 8% since 2007, in an industry where earnings elsewhere have yet to go beyond their 2008 peak. Furthermore, global spending on oil and gas exploration and production is set to grow by 6 per cent to 7 per cent next year, with Wood’s business expected to comfortably outperform this. On a bit more than 11 times’ earnings, they look like a good long-term bet, says The Times’s Tempus column.